Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orix (IX) Cash & Equivalents (2019 - 2025)

Orix (IX) has 16 years of Cash & Equivalents data on record, last reported at $7.9 billion in Q1 2025.

  • For Q1 2025, Cash & Equivalents changed N/A year-over-year to $7.9 billion; the TTM value through Mar 2025 reached $7.9 billion, changed N/A, while the annual FY2025 figure was $7.9 billion, N/A changed from the prior year.
  • Cash & Equivalents reached $7.9 billion in Q1 2025 per IX's latest filing, down from $9.3 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $9.3 billion in Q1 2023 and bottomed at $7.9 billion in Q1 2025.
  • Average Cash & Equivalents over 4 years is $8.6 billion, with a median of $8.6 billion recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: decreased 8.58% in 2022, then rose 13.35% in 2023.
  • A 4-year view of Cash & Equivalents shows it stood at $9.0 billion in 2021, then dropped by 8.58% to $8.2 billion in 2022, then grew by 13.35% to $9.3 billion in 2023, then fell by 15.08% to $7.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $7.9 billion in Q1 2025, $9.3 billion in Q1 2023, and $8.2 billion in Q1 2022.